A citation-based method for searching scientific literature

Chun-Cheng Chiang, Chau-Ting Yeh, Tsann-Long Hwang, Yu-De Chu, Siew-Na Lim, Chun-Wei Chen, Chia-Jung Kuo, Puo-Hsien Le, Tsung-Hsing Chen, Wey-Ran Lin. J Clin Med 2019
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Tian Huanna, Zuo Tao, Wang Xiangfei, An Longfei, Xie Yuanyuan, Wang Jianhua, Zhang Cuifang, Jiao Manjing, Cao Wenjing, Qin Shaochuan,[...]. Mol Carcinog 2015
44
66

Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and GALNT14 Genotype.
Tsung-Hsing Chen, Wey-Ran Lin, Chieh Lee, Cheng-Tang Chiu, Jun-Te Hsu, Ta-Sen Yeh, Kwang-Huei Lin, Puo-Hsien Le, Chau-Ting Yeh. J Cancer 2018
7
33



GALNT14 Involves the Regulation of Multidrug Resistance in Breast Cancer Cells.
Jinshuai Shan, Yang Liu, Yukun Wang, Yimiao Li, Xiaochun Yu, Chen Wu. Transl Oncol 2018
4
33

A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy.
Chen-Chun Lin, Chao-Wei Hsu, Yi-Cheng Chen, Ming-Ling Chang, Kung-Hao Liang, Ming-Wei Lai, Chih-Lang Lin, Rong-Nan Chien, Kwang-Huei Lin, Chau-Ting Yeh. Pharmacogenomics J 2020
2
50


GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.
Yung-Kuan Tsou, Kung-Hao Liang, Wey-Ran Lin, Hsien-Kun Chang, Chen-Kan Tseng, Chau-Ting Yeh. Oncotarget 2017
10
33

Mucin-type O-glycosylation and its potential use in drug and vaccine development.
Mads Agervig Tarp, Henrik Clausen. Biochim Biophys Acta 2008
209
33

Advances in pancreatic cancer biomarkers.
Syed Hasan, Rojymon Jacob, Upender Manne, Ravi Paluri. Oncol Rev 2019
40
33


GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
Ok-Seon Kwon, Ensel Oh, Jeong-Rak Park, Ji-Seon Lee, Gab-Yong Bae, Jae-Hyung Koo, Hyongbum Kim, Yoon L Choi, Young Soo Choi, Jhingook Kim,[...]. Oncotarget 2015
20
33

Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma.
Wey-Ran Lin, Chao-Wei Hsu, Christopher Sung-Huan Yeh, Yi-Cheng Chen, Ming-Ling Chang, Kung-Hao Liang, Chen-Chun Lin, Yu-De Chu, Chau-Ting Yeh. Asia Pac J Clin Oncol 2018
5
33

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
J Philip Kuebler, H Samuel Wieand, Michael J O'Connell, Roy E Smith, Linda H Colangelo, Greg Yothers, Nicholas J Petrelli, Michael P Findlay, Thomas E Seay, James N Atkins,[...]. J Clin Oncol 2007
688
33


A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients.
J Honing, J K Smit, C T Muijs, J G M Burgerhof, J W de Groot, G Paardekooper, K Muller, D Woutersen, M J C Legdeur, W E Fiets,[...]. Ann Oncol 2014
68
33

Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
Eric P Bennett, Ulla Mandel, Henrik Clausen, Thomas A Gerken, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2012
447
33


Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
Eung-Sirk Lee, Dae-Soon Son, Sung-Hyun Kim, Jinseon Lee, Jisuk Jo, Joungho Han, Heesue Kim, Hyun Joo Lee, Hye Young Choi, Youngja Jung,[...]. Clin Cancer Res 2008
184
33

A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma.
Chau-Ting Yeh, Kung-Hao Liang, Chen-Chun Lin, Ming-Ling Chang, Cheng-Lung Hsu, Chien-Fu Hung. Int J Cancer 2014
19
33

N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.
Chen Wu, Xiaodan Guo, Weina Wang, Yun Wang, Yaojun Shan, Bo Zhang, Wenqian Song, Sisi Ma, Jianfeng Ge, Hao Deng,[...]. BMC Cancer 2010
46
33

Osterix Decreases the Chemosensitivity of Breast Cancer Cells by Upregulating GALNT14.
Jiahui Wu, Xiang Chen, Qianyi Bao, Rui Duan, Yucui Jin, Yifang Shui, Bing Yao, Xiangdong Lu, Yue Wang, Hongyan Cui,[...]. Cell Physiol Biochem 2017
4
33

Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14.
Han Wang, Kouichi Tachibana, Yan Zhang, Hiroko Iwasaki, Akihiko Kameyama, Lamei Cheng, Jian ming Guo, Toru Hiruma, Akira Togayachi, Takashi Kudo,[...]. Biochem Biophys Res Commun 2003
71
33

Vertebrate protein glycosylation: diversity, synthesis and function.
Kelley W Moremen, Michael Tiemeyer, Alison V Nairn. Nat Rev Mol Cell Biol 2012
882
33


Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
Guillaume Piessen, Mathieu Messager, Emmanuelle Leteurtre, Triboulet Jean-Pierre, Christophe Mariette. Ann Surg 2009
191
33

Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
Razan Sheta, Magdalena Bachvarova, Marie Plante, Jean Gregoire, Marie-Claude Renaud, Alexandra Sebastianelli, Ion Popa, Dimcho Bachvarov. Int J Oncol 2017
14
33

Identification of GALNT14 as a novel neuroblastoma predisposition gene.
Marilena De Mariano, Roberta Gallesio, Marco Chierici, Cesare Furlanello, Massimo Conte, Alberto Garaventa, Michela Croce, Silvano Ferrini, Gian Paolo Tonini, Luca Longo. Oncotarget 2015
28
33


GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma.
Wey-Ran Lin, Chao-Wei Hsu, Yi-Cheng Chen, Ming-Ling Chang, Kung-Hao Liang, Ya-Hui Huang, Chau-Ting Yeh. Mol Clin Oncol 2014
11
33

Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab.
Howard M Stern, Mary Padilla, Klaus Wagner, Lukas Amler, Avi Ashkenazi. Clin Cancer Res 2010
29
33

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.
Boris Blechacz, Gregory J Gores. Hepatology 2008
487
33

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Kate Lancaster, Dori Lee, Melissa von Goetz, Sharon Fong Yee, Klara Totpal,[...]. Nat Med 2007
431
33

BORIS Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through GALNT14.
Joanna C Hillman, Elena M Pugacheva, Carter J Barger, Sirinapa Sribenja, Spencer Rosario, Mustafa Albahrani, Alexander M Truskinovsky, Aimee Stablewski, Song Liu, Dmitri I Loukinov,[...]. Mol Cancer Res 2019
11
33

Mucin-type O-glycosylation during development.
Duy T Tran, Kelly G Ten Hagen. J Biol Chem 2013
154
33


Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
Thierry André, Corrado Boni, Lamia Mounedji-Boudiaf, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Marta Zaninelli, Philip Clingan, John Bridgewater,[...]. N Engl J Med 2004
33

GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Kung-Hao Liang, Chih-Lang Lin, Sung-Fang Chen, Chih-Wei Chiu, Pei-Ching Yang, Ming-Ling Chang, Chen-Chun Lin, Kai-Feng Sung, Cassandra Yeh, Chien-Fu Hung,[...]. Pharmacogenomics 2016
12
33

All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.
Kelly G Ten Hagen, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2003
344
33


Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Hanna K Sanoff, William R Carpenter, Christopher F Martin, Daniel J Sargent, Jeffrey A Meyerhardt, Til Stürmer, Jason P Fine, Jane Weeks, Joyce Niland, Katherine L Kahn,[...]. J Natl Cancer Inst 2012
68
33

GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
Wey-Ran Lin, Jy-Ming Chiang, Kung-Hao Liang, Siew-Na Lim, Ming-Wei Lai, Yung-Kuan Tsou, Tzu-Yun Hsieh, Chih-Kai Hsu, Chau-Ting Yeh. Medicine (Baltimore) 2016
11
33

GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment.
Ki-Hoon Song, Mi So Park, Tulip S Nandu, Shrikanth Gadad, Sang-Cheol Kim, Mi-Young Kim. Nat Commun 2016
34
33

EFEMP2 Mediates GALNT14-Dependent Breast Cancer Cell Invasion.
Tao Zuo, Jinshuai Shan, Yang Liu, Rong Xie, Xiaochun Yu, Chen Wu. Transl Oncol 2018
9
33

Amyloid deposition, hypometabolism, and longitudinal cognitive decline.
Susan M Landau, Mark A Mintun, Abhinay D Joshi, Robert A Koeppe, Ronald C Petersen, Paul S Aisen, Michael W Weiner, William J Jagust. Ann Neurol 2012
379
33

CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects.
Michael Ewers, Philip Insel, William J Jagust, Leslie Shaw, John Q Trojanowski, Paul Aisen, Ronald C Petersen, Norbert Schuff, Michael W Weiner. Cereb Cortex 2012
76
33

Measuring cognition and function in the preclinical stage of Alzheimer's disease.
Sandra Weintraub, Maria C Carrillo, Sarah Tomaszewski Farias, Terry E Goldberg, James A Hendrix, Judith Jaeger, David S Knopman, Jessica B Langbaum, Denise C Park, Michael T Ropacki,[...]. Alzheimers Dement (N Y) 2018
43
33

The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum.
Sung Hoon Kang, Yu Hyun Park, Daun Lee, Jun Pyo Kim, Juhee Chin, Yisuh Ahn, Seong Beom Park, Hee Jin Kim, Hyemin Jang, Young Hee Jung,[...]. Dement Neurocogn Disord 2019
49
33

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Willemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, Betty M Tijms, Philip Scheltens, Frans R J Verhey, Pieter Jelle Visser, Pauline Aalten, Dag Aarsland, Daniel Alcolea,[...]. JAMA 2015
748
33

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Rik Ossenkoppele, Willemijn J Jansen, Gil D Rabinovici, Dirk L Knol, Wiesje M van der Flier, Bart N M van Berckel, Philip Scheltens, Pieter Jelle Visser, Sander C J Verfaillie, Marissa D Zwan,[...]. JAMA 2015
315
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.